Polypharmacy is a cost and safety problem that is solvable. The right technology platform can reduce it by identifying risky regimens, route specific “stop/switch/consolidate” opportunities to clinicians, and track whether changes stick through refill and adherence patterns.
The post Chronic Overmedication: The Polypharmacy Waste and Safety Problem appeared first on MedCity News.
